Pan-cancer analysis combined with experimental validation revealed IL4I1 as an immunological and prognostic biomarker.

Rao D, Yu C, Wang T, Sheng J, Lv E, Liang H, Huang W, Dong H
Int Immunopharmacol. 2022 Oct;111:109091. doi: 10.1016/j.intimp.2022.109091. Epub 2022 Aug 8. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.